Latest News for: trem2

Edit

Vigil Neuroscience Presents Data on its Small Molecule TREM2 Agonist VG-3927 in Two Oral

Hastings Tribune 02 Apr 2025
- Preclinical presentation highlights key, modality specific, pharmacological differentiations of VG-3927 - ... .
Edit

Vigil Neuroscience Presents Data on its Small Molecule TREM2 Agonist VG-3927 in Two Oral Presentations ...

Nasdaq Globe Newswire 02 Apr 2025
- Preclinical presentation highlights key, modality specific, pharmacological differentiations of VG-3927 - ... .
Edit

iTeos to Present Preclinical Data on Potential Best-In-Class Anti-TREM2 Antibody, EOS-215, and Novel PTPN1/2 Inhibitor ...

Nasdaq Globe Newswire 25 Mar 2025
ITOS), a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation ...
Edit

Acute TREM2 inhibition depletes MAFB-high microglia and hinders remyelination

PNAS 25 Mar 2025
Remyelination repairs ... .
  • 1

Article Search

tools
×
×
×
×